Document is current
Any future updates will be listed below
-
Authors
Eide, Per Kristian
Hovd, Markus
Pripp, Are
Gjertsen, Øivind
Løvland, Grethe
Lashkarivand, Aslan
Lindstrøm, Erika
Valnes, Lars Magnus
Ringstad, Geir
-
Funding
Funding for this research was provided by:
University of Oslo
- License Information
-
More Information
Article History
Received: 10 March 2025
Accepted: 23 June 2025
First Online: 1 July 2025
Declarations
:
: Per Kristian Eide and Geir Ringstad are shareholders in BrainWideSolutions AS, Oslo, Norway, which is a holder of patents US 11,272,841 and US 12,016,651-B2.
: The study received approval from the following authorities: (i) The Institutional Review Board of Oslo University Hospital (2015/1868) where the study was registered in Oslo University Hospital Research Registry (ePhorte 2015/1868). (ii) The Regional Committee for Medical and Health Research Ethics (REK) of Health Region South-East, Norway (2015/96). (iii) The National Medicines Agency of Norway (15/04932-7). The study adhered to the ethical standards outlined in the Declaration of Helsinki (1975, revised in 1983). All participants provided written and oral informed consent before inclusion. The study design was prospective and observational, and as such sample size calculations and patient randomization were not considered relevant.
